SCHEMBL1509253

SCHEMBL1509253

O=C(O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1-c1c(C(=O)O)cc([N+](=O)[O-])cc1[N+](=O)[O-]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
ALDH1A1 P00352 5/20 0.54
LMNA P02545 1/20 0.54
HKDC1 Q2TB90 1/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
HPGD P15428 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GPR35 Q9HC97 4/20 0.48
MAPT P10636 3/20 0.48
ALOX15 P16050 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
MAPK1 P28482 2/20 0.48
KDM4E B2RXH2 1/20 0.48
TTR P02766 1/20 0.48
ALOX12 P18054 1/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27738271 0.87 CRHBP (0.50) CA1CA2ALDH1A1LMNAKMT2A
SCHEMBL7822479 0.85 ALDH1A1 (0.50) CA1CA2ALDH1A1LMNAHKDC1
SCHEMBL10528832 0.85 HKDC1 (0.71) CA1CA2ALDH1A1LMNAHKDC1
SCHEMBL27759110 0.84 CRHBP (0.51) CA1CA2ALDH1A1LMNAKMT2A
SCHEMBL4850974 0.83 CA1 (0.54) CA1CA2ALDH1A1LMNAKMT2A
3,5-Dinitrosalicylic Acid SCHEMBL28323234 0.83 ALDH1A1 (0.61) CA1CA2ALDH1A1LMNAKMT2A
3,5-Dinitrosalicylic Acid SCHEMBL125292 0.83 ALDH1A1 (0.61) CA1CA2ALDH1A1LMNAKMT2A
SCHEMBL11072023 0.83 CA1 (0.69) CA1CA2ALDH1A1LMNAKMT2A
3,5-Dinitrosalicylic Acid SCHEMBL29350581 0.83 ALDH1A1 (0.61) CA1CA2ALDH1A1LMNAKMT2A
SCHEMBL394667 0.81 TSHR (0.57) CA1CA2ALDH1A1LMNAHKDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2291077-A1 PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS Inspire Pharmaceuticals, Inc. (US) 2011-03-09 EP disclosed
WO-2009154940-A1 PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS INSPIRE PHARMACEUTICALS, INC. (US) 2009-12-23 WO disclosed